Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Akari Therapeutics (AKTX)

$1.29 0.13 (11.03%)

16:00 EDT AKTX Stock Quote Delayed 20 Minutes

Volume:

Previous Close $1.29

Market Cap 19.68M

PE Ratio -

EPS -

Volume (Avg. Vol.) 117,100

Day's Range 1.15 - 1.32

52-Week Range 0.87 - 5.04

Dividend & Yield N/A (N/A)

AKTX Stock Predictions, Articles, and Akari Therapeutics News

From InvestorPlace
From the Web

Biopharma News: Why Akari Therapeutics (AKTX) Stock Is Soaring Today

By William White, InvestorPlace Writer Aug 14, 2019

Some recent biopharma news concerning Akari Therapeutics getting Fast Track approval from the FDA has AKTX stock flying high on Wednesday.

3 Stocks to Watch on Friday: BlackBerry Ltd (BBRY), Akari Therapeutics PLC (ADR) (AKTX) and Voxeljet AG (ADR) (VJET)

By Karl Utermohlen, InvestorPlace Writer Mar 31, 2017

BlackBerry (BBRY) and VoxelJet (VJET) were moving Friday on earnings, while Akari Therapeutics (AKTX) received some positive medical news.

The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO

From Benzinga Mar 12, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...

The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment

From Benzinga Mar 11, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics...

The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion

From Benzinga Feb 21, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics...

Akari Therapeutics up 6% on encouraging nomacopan data

From Seeking Alpha Jan 27, 2020

Thinly traded nano cap Akari Therapeutics (AKTX +5.9%) is up on average volume in reaction to preclinical data on a long-acting version of lead drug nomacopan (PAS-nomacopan) that, it says, supports i

Akari Therapeutics (NASDAQ:AKTX) Will Have To Spend Its Cash Wisely

From Simply Wall St Jan 14, 2020

There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aktx/akari-therapeutics/news/akari-therapeutics-nasdaqaktx-will-have-to-spend-its-cash-wisely/">Read More...</a></div>

Best & Worst Performing Small Cap Stocks for January 10, 2020

From StockNews.com Jan 10, 2020

CPAH – CPAH leads the way today as the best performing small cap stock, closing up 295.96%.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell